Certainly the most important involved the reelection of Boris Yeltsin as President of Russia--a positive development for democracy abroad, and a defeat for the Communist Party there that unfortunately maintains the support of a sizable portion of the electorate. Another election that might have gone otherwise unnoticed, except for the stunning results which it produced, occurred in Mongolia on June 30. I had the opportunity to join with former Secretary of State Jim Baker and several other distinguished observers in visiting polling stations across the plains of Mongolia to watch democracy in action. Mr. President, what occurred in Mongolia a week ago Sunday was truly historic. Parliamentary elections there produced dramatic results: Democratic reformers upended the ruling former Communist Party seized majority control of the legislature for the first time, and are now in position to set this vast country on a bold new course. The seismic political shift in Mongolia was unexpected, to say the least.
Editor's note · Context
Discussing international elections, particularly the reelection of Boris Yeltsin and the elections in Mongolia.
Share
More from Charles Robb
the suspense regarding this particular vote is long over, but the date on the effect and implications of PNTR in China is really just beginning. My rationale for supporting PNTR differs in some respects from my colleagues, who have mostly…
we may not have any more important debate this session than the one we are having now on the reauthorization of the major piece of federal legislation affecting K-12 education, the Elementary and Secondary Education Act. I was pleased to…
I am supporting the fiscal year 2001 Defense Appropriations Act with a very mixed sense of frustrated resignation and expectant hope for the way we are resourcing our national defense. A major source of frustration this year is that we…
2 weeks ago, at a health care forum I sponsored in Virginia, a doctor told me of a woman with breast cancer splitting her Tamoxofin pills with two other breast cancer patients, because the drug was so expensive that the other two couldn't…





